CC
IOVA icon

Centiva Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Centiva Capital’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,312
Closed -$202K – 1833
2024
Q4 		$202K Buy
27,312
+10,687
+64% +$99.1K 0.01% 1363
2024
Q3 		$156K Buy
+16,625
New +$158K 0.01% 1894
2024
Q2 		– Sell
-11,030
Closed -$163K – 2291
2024
Q1 		$163K Buy
+11,030
New +$128K 0.01% 1524
2021
Q2 		– Sell
-9,897
Closed -$313K – 1507
2021
Q1 		$313K Buy
9,897
+4,894
+98% +$203K 0.04% 741
2020
Q4 		$232K Buy
+5,003
New +$199K 0.03% 737
2019
Q4 		– Sell
-14,341
Closed -$261K – 882
2019
Q3 		$261K Buy
+14,341
New +$317K 0.06% 460

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return